147 related articles for article (PubMed ID: 16143444)
1. The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors.
Trinh XB; Van Hal G; Weyler J; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):207-11. PubMed ID: 16143444
[TBL] [Abstract][Full Text] [Related]
2. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
Trinh XB; Peeters F; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
[TBL] [Abstract][Full Text] [Related]
3. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
Lash TL; Gurwitz JH; Silliman RA
J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
[TBL] [Abstract][Full Text] [Related]
4. Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong K; Quistberg DA; Micco E; Domchek S; Guerra C
Arch Intern Med; 2006 Nov; 166(20):2260-5. PubMed ID: 17101945
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.
Elinson L; Cohen MM; Elmslie T
CMAJ; 1999 Sep; 161(6):695-8. PubMed ID: 10513275
[TBL] [Abstract][Full Text] [Related]
6. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
8. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
Thunell L; Milsom I; Schmidt J; Mattsson LA
BJOG; 2006 Jan; 113(1):15-20. PubMed ID: 16398765
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in breast cancer survivors.
Xydakis AM; Sakkas EG; Mastorakos G
Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in Brazilian breast cancer survivors age 45-65 years: associated factors.
Conde DM; Pinto-Neto AM; Cabello C; Santos-Sá D; Costa-Paiva L; Martinez EZ
Breast J; 2005; 11(6):425-32. PubMed ID: 16297087
[TBL] [Abstract][Full Text] [Related]
11. Willingness to follow breast cancer. Survey of family physicians.
Worster A; Bass MJ; Wood ML
Can Fam Physician; 1996 Feb; 42():263-8. PubMed ID: 9222575
[TBL] [Abstract][Full Text] [Related]
12. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
13. A survey among breast cancer survivors: treatment of the climacteric after breast cancer.
Antoine C; Vandromme J; Fastrez M; Carly B; Liebens F; Rozenberg S
Climacteric; 2008 Aug; 11(4):322-8. PubMed ID: 18645698
[TBL] [Abstract][Full Text] [Related]
14. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
Castelo-Branco C; Ferrer J; Palacios S; Cornago S
Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
[TBL] [Abstract][Full Text] [Related]
15. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
16. Tibolone therapy in breast cancer survivors: a retrospective study.
Goutzioulis M; Vavilis D; Agorastos T; Konstantinidis T; Pantazis K; Goutzioulis A; Goulis DG; Makedos G; Bontis JN
J Obstet Gynaecol Res; 2007 Feb; 33(1):68-73. PubMed ID: 17212669
[TBL] [Abstract][Full Text] [Related]
17. Current trends in hormone replacement therapy: perceptions and usage.
Birkhäuser MH; Reinecke I
Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
[TBL] [Abstract][Full Text] [Related]
18. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
Antoine C; Ameye L; Paesmans M; Rozenberg S
Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
20. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
